Invasive candidosis in pediatric patients

Clinical Microbiology and Infection

Volumn 3, Issue 2, 1997, Pages 192-197

  Roilides, Emmanuel ^a,b   Kadiltsoglou, Isaac ^a   Zahides, Dimitrios ^b   Bibashi, Evangelia ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Aristotle University of Thessaloniki   (Greece)

Author keywords

Candida; Children; Invasive candidosis; Nosocomial infections

Indexed keywords

ANTIFUNGAL AGENT; PYRROLE DERIVATIVE;

ADOLESCENT; ARTICLE; BLOOD CULTURE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDIASIS; CHILD; CLINICAL ARTICLE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFANT; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NEWBORN; PEDIATRICS; PREMATURITY; PRIORITY JOURNAL; TREATMENT OUTCOME; URINE CULTURE;

EID: 0030910182     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1997.tb00597.x     Document Type: Article

References (20)

1. Horn R, Wong B, Kiehn TE, Armstrong D. Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Rev Infect Dis 1985; 7: 646-55.
2. Klein JJ, Watanakunakorn C. Hospital acquired fungemia: its natural course and clinical significance. Am J Med 1979; 67: 51-8.
3. Nielsen H, Stenderup J, Bruun B. Fungemia in a university hospital 1984-1988. Scand J Infect Dis 1991; 23: 275-82.
4. Wajszczuk CP, Dummer JS, Ho M, et al. Fungal infections in liver transplant recipients. Transplantation 1985; 40: 347-53.
5. Beck-Sague CM, Jarvis WR, the National Nosocomial Infections Surveillance System. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J Infect Dis 1993; 167: 1247-51.
6. Butler KM, Baker CJ. Candida: an increasingly important pathogen in the nursery. Pediatr Clin North Am 1988; 35: 543-63.
7. Pizzo PA, Walsh TJ. Fungal infections in the pediatric cancer patient. Semin Oncol 1990; 17(suppl 6): 6-9.
8. Walsh TJ, Gonzalez C, Roilides E, et al. Fungemia in children infected with the human immunodeficiency virus: new epidemiologic patterns, emerging pathogens, and improved outcome with antifungal therapy. Clin Infect Dis 1995; 20: 900-6.
9. Stamos JK, Rowley AH. Candidemia in a pediatric population. Clin Infect Dis 1995; 20: 571-5.
10. Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 1992; 15: 414-21.
11. MacDonald L, Baker C, Nadjarian R, Chenoweth C. Risk factors for nosocomial candidemia in a pediatric hospital [abstract J108]. In: Program and Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL. Washington, DC: American Society for Microbiology, 1994: 106.
12. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts; proposed standard. Villanova, Pennsylvania: NCCLS, 1992.
13. Faix RG. Invasive neonatal candidiasis: comparison of albicans and parapsilosis infection. Pediatr Infect Dis J 1992; 11: 88-93.
14. Pfaller MA. Epidemiology and control of fungal infections. Clin Infect Dis 1994; 19(suppl 1): 8-11.
15. Drossou-Agakidou V, Sarafidis K, Papakyriakidou P, Kremenopoulos G. Fungal sepsis in very low birth weight neonates. Pediatriki North Greece 1994; 6: 32-6.
16. Dato VM, Dajani AS. Candidemia in children with central venous catheters: role of catheter removal and amphotericin B therapy. Pediatr Infect Dis J 1990; 9: 309-14.
17. Lecciones JA, Lee JW, Navarro EE, et al. Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes. Clin Infect Dis 1992; 14: 875-83
18. Koupari G, Themeli K, Kourakis G, Kallergi K, Dellagrammatikas E, Kremastinou T. Systemic candidiasis in neonatal intensive care unit. Acta Microbiol Hell 1988; 33: 246-52.
19. Rex JH, Pfaller MA, Barry AL, et al. Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole vs. amphotericin B as treatment of non-neutropenic patients with candidemia. Antimicrob Agents Chemother 1995; 39: 40-4.
20. PfaLLer MA, Rhine-Chalberg J, Barry AL, Rex JH, NIAID Mycoses Study Group and the Candidemia Study Group. Strain variation and antifungal susceptibility among bloodstream isolates of Candida species from 21 different medical institutions. Clin Infect Dis 1995; 21: 1507-9.